✦ LIBER ✦

Anti–IL-5 (mepolizumab) therapy does not alter IL-5 receptor α levels in patients with eosinophilic esophagitis

✍ Scribed by Conus, Sébastien; Straumann, Alex; Simon, Hans-Uwe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti–IL-5 (mepolizumab) therapy reduces

✍ Stein, Miguel L.; Villanueva, Joyce M.; Buckmeier, Bridget K.; Yamada, Yoshiyuki 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 963 KB

Anti-IL-5 Therapy (Mepolizumab) in Hyper

✍ Stein, M.L.; Villanueva, J.M.; Jameson, S.C.; Buckmeier, B.; Filipovich, A.H.; C 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 198 KB

IL-5 receptor α levels in patients with

✍ Wilson, Todd M.; Maric, Irina; Shukla, Juhi; Brown, Margaret; Santos, Carlo; Sim 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 596 KB

The Pharmacodynamic Effects of Mepolizum

✍ Assa'ad, A.; Aceves, S.; Gupta, S.; Drouin, É.; Collins, M.; Jurgensen, C.; Heat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 41 KB